Use of nucleotyping and tumor stroma ratio to predict prognosis in patients with resected intestinal-type gastric cancer. A study of the homologous recombination deficiency signature (HRDSig) status ...

The addition of sintilimab to neoadjuvant chemoradiotherapy achieved a 60% pathological complete response rate vs 47.3% with ...